X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with Sterling Biotech - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs STERLING BIOTECH - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD STERLING BIOTECH MERCK LTD/
STERLING BIOTECH
 
P/E (TTM) x 26.1 -1.8 - View Chart
P/BV x 2.9 0.1 4,206.4% View Chart
Dividend Yield % 1.0 0.0 -  

Financials

 MERCK LTD   STERLING BIOTECH
EQUITY SHARE DATA
    MERCK LTD
Dec-16
STERLING BIOTECH
Dec-13
MERCK LTD/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs1,06011 10,095.2%   
Low Rs6233 18,323.5%   
Sales per share (Unadj.) Rs632.426.8 2,359.2%  
Earnings per share (Unadj.) Rs45.7-15.0 -305.7%  
Cash flow per share (Unadj.) Rs62.3-5.5 -1,140.7%  
Dividends per share (Unadj.) Rs11.000-  
Dividend yield (eoy) %1.30-  
Book value per share (Unadj.) Rs388.854.9 708.5%  
Shares outstanding (eoy) m16.60267.87 6.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.30.3 513.2%   
Avg P/E ratio x18.4-0.5 -3,961.3%  
P/CF ratio (eoy) x13.5-1.3 -1,061.4%  
Price / Book Value ratio x2.20.1 1,709.0%  
Dividend payout %24.10-   
Avg Mkt Cap Rs m13,9691,862 750.3%   
No. of employees `0001.61.4 116.9%   
Total wages/salary Rs m1,487547 271.9%   
Avg. sales/employee Rs Th6,631.95,303.3 125.1%   
Avg. wages/employee Rs Th939.2403.8 232.6%   
Avg. net profit/employee Rs Th479.4-2,959.0 -16.2%   
INCOME DATA
Net Sales Rs m10,4987,181 146.2%  
Other income Rs m24243 569.0%   
Total revenues Rs m10,7417,223 148.7%   
Gross profit Rs m1,135947 119.9%  
Depreciation Rs m2762,543 10.8%   
Interest Rs m04,377 0.0%   
Profit before tax Rs m1,102-5,931 -18.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m343-1,924 -17.8%   
Profit after tax Rs m759-4,007 -18.9%  
Gross profit margin %10.813.2 82.0%  
Effective tax rate %31.132.4 96.0%   
Net profit margin %7.2-55.8 -13.0%  
BALANCE SHEET DATA
Current assets Rs m6,41014,335 44.7%   
Current liabilities Rs m8,82849,809 17.7%   
Net working cap to sales %-23.0-494.0 4.7%  
Current ratio x0.70.3 252.3%  
Inventory Days Days58403 14.3%  
Debtors Days Days38171 22.5%  
Net fixed assets Rs m1,40655,432 2.5%   
Share capital Rs m166268 62.0%   
"Free" reserves Rs m6,28613,935 45.1%   
Net worth Rs m6,45514,701 43.9%   
Long term debt Rs m09,478 0.0%   
Total assets Rs m8,82873,988 11.9%  
Interest coverage xNM-0.4-  
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x1.20.1 1,225.3%   
Return on assets %8.60.5 1,716.2%  
Return on equity %11.8-27.3 -43.1%  
Return on capital %17.1-6.4 -265.7%  
Exports to sales %8.325.9 32.0%   
Imports to sales %21.00.2 12,385.8%   
Exports (fob) Rs m8691,860 46.7%   
Imports (cif) Rs m2,20912 18,108.2%   
Fx inflow Rs m9591,860 51.6%   
Fx outflow Rs m2,61225 10,494.2%   
Net fx Rs m-1,6531,835 -90.1%   
CASH FLOW
From Operations Rs m1,0701,719 62.3%  
From Investments Rs m-750-3,148 23.8%  
From Financial Activity Rs m-1501,426 -10.5%  
Net Cashflow Rs m171-3 -5,026.5%  

Share Holding

Indian Promoters % 0.0 33.9 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 0.0 -  
FIIs % 1.0 9.9 10.1%  
ADR/GDR % 0.0 16.9 -  
Free float % 29.1 39.3 74.0%  
Shareholders   28,591 21,482 133.1%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   GLENMARK PHARMA  FULFORD INDIA  DR. REDDYS LAB  DIVIS LABORATORIES  UNICHEM LAB  

Compare MERCK LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Green; Bank Stocks Witness Selling(01:30 pm)

After opening the day on a flat note, the Indian share markets have reversed the trend and are currently trading above the dotted line.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Aug 17, 2017 03:37 PM

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MERCK LTD - DISHMAN PHARMA COMPARISON

COMPARE MERCK LTD WITH

MARKET STATS